LHON Main Diagnostic de la NOHL : sensibiliser le public à la souffran... Maryse Roger a vécu de près la neuropathie optique héréditaire de Leber (NOHL).
Views & Analysis LHON diagnosis: Opening peoples’ eyes to the invisible suffe... Maryse Roger has firsthand experience of Leber’s hereditary optic neuropathy (LHON), having first assisted her two brothers as their sight deteriorated and then leading the care of her son
News Scribe Therapeutics joins the IPO queue Scribe Therapeutics has become the latest biotech to announce plans to list on the Nasdaq as it advances its spin on CRISPR-based therapeutics.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
